00775.HK
CK Life Sciences Int'l., (Holdings) Inc.
HKSE · Healthcare · Biotechnology · HK
HKD 0.59
+0.85%Margins
Gross margin
22.0%
EBITDA margin
0.8%
EBIT margin
5.4%
Net margin
-3.1%
FCF margin
-2.9%
-8.7%
Return on equity
-2.8%
Return on assets
5.5%
Return on invested capital
0.92x
Asset turnover
HKD 125.4M
Cash from operations
HKD 0.06
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026